1
|
Mai T, Takano A, Suzuki H, Hirose T, Mori T, Teramoto K, Kiyotani K, Nakamura Y, Daigo Y. Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine. Oncol Lett 2017; 14:283-292. [PMID: 28693166 DOI: 10.3892/ol.2017.6125] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2016] [Accepted: 03/03/2017] [Indexed: 12/31/2022] Open
Abstract
With the development of cancer immunotherapy that may activate T cells, a practical and quantitative method to improve monitoring and/or prediction of immunological response of patients as a predictive biomarker is of importance. To examine possible biomarkers for a therapeutic cancer vaccine containing a mixture of three epitope peptides derived from cell division-associated 1, lymphocyte antigen 6 complex locus K and insulin-like growth factor-II mRNA-binding protein 3, T-cell receptor β (TCRβ) repertoires of blood samples from 24 patients with human leukocyte antigen-A*2402-positive non-small cell lung cancer were characterized prior to and following 8 weeks of the cancer vaccine treatment, by applying a next-generation sequencing method. It was identified that 14 patients with overall survival (OS) times of ≥12 months had significantly lower TCRβ diversity indexes in samples prior to treatment, compared with 10 patients who succumbed within 1 year (P=0.03). In addition, patients with a high level of activated CD8+ T cells that are defined by a high granzyme A/CD8 ratio had favorable OS rates (log-rank test, P=0.04). The TCRβ diversity index and immunogenic gene markers following vaccine administration may serve as predictive or monitoring biomarkers for cancer vaccine treatment.
Collapse
Affiliation(s)
- Tu Mai
- Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL 60637, USA.,Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA
| | - Atsushi Takano
- Department of Medical Oncology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.,Cancer Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
| | - Hiroyuki Suzuki
- Department of Regenerative Surgery, Fukushima Medical University, School of Medicine, Fukushima 960-1295, Japan
| | - Takashi Hirose
- Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan
| | - Takahiro Mori
- Tohoku Community Cancer Services Program, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8574, Japan
| | - Koji Teramoto
- Department of Medical Oncology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.,Cancer Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
| | - Kazuma Kiyotani
- Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA
| | - Yusuke Nakamura
- Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL 60637, USA.,Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.,Department of Surgery, University of Chicago, Chicago, IL 60637, USA
| | - Yataro Daigo
- Department of Medical Oncology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.,Cancer Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
| |
Collapse
|
2
|
Cao H, Hastie AR, Cao D, Lam ET, Sun Y, Huang H, Liu X, Lin L, Andrews W, Chan S, Huang S, Tong X, Requa M, Anantharaman T, Krogh A, Yang H, Cao H, Xu X. Rapid detection of structural variation in a human genome using nanochannel-based genome mapping technology. Gigascience 2014; 3:34. [PMID: 25671094 PMCID: PMC4322599 DOI: 10.1186/2047-217x-3-34] [Citation(s) in RCA: 114] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Accepted: 11/28/2014] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Structural variants (SVs) are less common than single nucleotide polymorphisms and indels in the population, but collectively account for a significant fraction of genetic polymorphism and diseases. Base pair differences arising from SVs are on a much higher order (>100 fold) than point mutations; however, none of the current detection methods are comprehensive, and currently available methodologies are incapable of providing sufficient resolution and unambiguous information across complex regions in the human genome. To address these challenges, we applied a high-throughput, cost-effective genome mapping technology to comprehensively discover genome-wide SVs and characterize complex regions of the YH genome using long single molecules (>150 kb) in a global fashion. RESULTS Utilizing nanochannel-based genome mapping technology, we obtained 708 insertions/deletions and 17 inversions larger than 1 kb. Excluding the 59 SVs (54 insertions/deletions, 5 inversions) that overlap with N-base gaps in the reference assembly hg19, 666 non-gap SVs remained, and 396 of them (60%) were verified by paired-end data from whole-genome sequencing-based re-sequencing or de novo assembly sequence from fosmid data. Of the remaining 270 SVs, 260 are insertions and 213 overlap known SVs in the Database of Genomic Variants. Overall, 609 out of 666 (90%) variants were supported by experimental orthogonal methods or historical evidence in public databases. At the same time, genome mapping also provides valuable information for complex regions with haplotypes in a straightforward fashion. In addition, with long single-molecule labeling patterns, exogenous viral sequences were mapped on a whole-genome scale, and sample heterogeneity was analyzed at a new level. CONCLUSION Our study highlights genome mapping technology as a comprehensive and cost-effective method for detecting structural variation and studying complex regions in the human genome, as well as deciphering viral integration into the host genome.
Collapse
Affiliation(s)
- Hongzhi Cao
- />BGI-Shenzhen, Shenzhen, 518083 China
- />Shenzhen Key Laboratory of Transomics Biotechnologies, Shenzhen, 518083 China
- />Department of Biology, University of Copenhagen, Copenhagen, 2200 Denmark
| | | | - Dandan Cao
- />BGI-Shenzhen, Shenzhen, 518083 China
- />Shenzhen Key Laboratory of Transomics Biotechnologies, Shenzhen, 518083 China
| | - Ernest T Lam
- />BioNano Genomics, San Diego, California 92121 USA
| | - Yuhui Sun
- />BGI-Shenzhen, Shenzhen, 518083 China
- />School of Bioscience and Biotechnology, South China University of Technology, Guangzhou, 511400 China
| | - Haodong Huang
- />BGI-Shenzhen, Shenzhen, 518083 China
- />School of Bioscience and Biotechnology, South China University of Technology, Guangzhou, 511400 China
| | - Xiao Liu
- />BGI-Shenzhen, Shenzhen, 518083 China
- />Department of Biology, University of Copenhagen, Copenhagen, 2200 Denmark
| | - Liya Lin
- />BGI-Shenzhen, Shenzhen, 518083 China
- />School of Bioscience and Biotechnology, South China University of Technology, Guangzhou, 511400 China
| | | | - Saki Chan
- />BioNano Genomics, San Diego, California 92121 USA
| | - Shujia Huang
- />BGI-Shenzhen, Shenzhen, 518083 China
- />School of Bioscience and Biotechnology, South China University of Technology, Guangzhou, 511400 China
| | - Xin Tong
- />BGI-Shenzhen, Shenzhen, 518083 China
| | | | | | - Anders Krogh
- />Department of Biology, University of Copenhagen, Copenhagen, 2200 Denmark
| | - Huanming Yang
- />BGI-Shenzhen, Shenzhen, 518083 China
- />Shenzhen Key Laboratory of Transomics Biotechnologies, Shenzhen, 518083 China
| | - Han Cao
- />BioNano Genomics, San Diego, California 92121 USA
| | - Xun Xu
- />BGI-Shenzhen, Shenzhen, 518083 China
- />Shenzhen Key Laboratory of Transomics Biotechnologies, Shenzhen, 518083 China
| |
Collapse
|